Through NGS based genetic testing, iGenetic can provide a risk assessment for several hereditary cancers so that the clinician and patient can determine the appropriate intervention.
Using a customized panel of 86 genes, iGenetic can leverage its NGS technology to assess the risk of 32 inherited cancers. This is valuable information for patients who have a history of hereditary cancers in the family as it can help the clinician and patient determine appropriate intervention.
Inherited Cancer Screening on NGS Platform
|Next Generation Sequencing||4-6 weeks||EDTA Blood|
|Method||Next Generation Sequencing|
|Sample required||EDTA Blood|
Please contact us by phone or email to schedule a test.